Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00714532 · ClinicalTrials.gov registry record · NA
Smoking Reduction and Cessation Interventions for Chinese
A NA study of Smoking Cessation, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 298
- Enrollment target
- 1
- Study location
NCT00714532: Completed NA study of Smoking Cessation, sponsored by University of California, San Francisco.
NCT00714532 is a NA study of Smoking Cessation that has completed, run by University of California, San Francisco. The registered enrollment target is 298 participants, below the 473-participant average among 188 other Smoking Cessation trials with a reported enrollment target (37% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00714532, a NA study of Smoking Cessation, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 298 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims at developing and testing a stage-based scheduled smoking intervention that targets to encourage smokers to reduce smoking and to facilitate smoking abstinence. We hypothesize that smokers who receive the staged-based scheduled smoking intervention will be more likely to report smoking abstinence, quit attempts, and smoking reduction at 12 months.
Conditions Studied
Interventions
- BEHAVIORAL Expert System Only
- BEHAVIORAL Enhanced Expert System
Study Locations (1)
California
- UCSF Langley Porter - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 298 participants |
| Start Date | 2007-04 |
| Est. Completion | 2009-06 |
| Phase | NA |
What the finished NCT00714532 record still lists
NCT00714532 is an interventional study that assigns participants to a tested intervention. The registered 298 participants enrollment target is mid-sized for trials with a published cap, below the 473-participant average among 188 other Smoking Cessation trials with a reported enrollment target (37% lower).
The record links to 1 condition, with Smoking Cessation appearing as the primary indexed condition, and to 2 interventions - of which Expert System Only is the first listed.
NCT00714532 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00714532 about?
NCT00714532 is a clinical study titled "Smoking Reduction and Cessation Interventions for Chinese". This study aims at developing and testing a stage-based scheduled smoking intervention that targets to encourage smokers to reduce smoking and to facilitate smoking abstinence. We hypothesize that smokers who receive the staged-based scheduled smoking intervention will be more likely to report smoki...
What is the current status of trial NCT00714532?
This trial is currently completed. It is a NA study. The enrollment target is 298 participants. The study started on 2007-04. Estimated completion is 2009-06.
What conditions does trial NCT00714532 study?
This clinical trial studies the following conditions: Smoking Cessation.
What interventions are being tested in trial NCT00714532?
The interventions under investigation include: Expert System Only (BEHAVIORAL), Enhanced Expert System (BEHAVIORAL).
Who is sponsoring clinical trial NCT00714532?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00714532 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00714532's enrollment target sits among peer trials
298 83rd of 188 higher than 106 of 188 other Smoking Cessation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Research Evaluating Smoking Cessation With E-Cigarettes and Nicotine Therapy
RECRUITING · NA
-
Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors
RECRUITING · NA
-
ACT Lung Health Intervention: Phase Two
RECRUITING · NA
-
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
RECRUITING · NA
-
Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women
RECRUITING · NA
-
Urban and Reservation Implementation of All Nations Breath of Life
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06305624 · 298 participants · NA
Implementation of Mobile-based Programs for Alcohol Cessation in Treatment of Alcohol-associated Liver Disease
- NCT06754215 · 298 participants · NA
Smoking Cessation Intervention Development for Homeless Youth
- NCT06780111 · 298 participants · Phase 1
Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)
- NCT07209358 · 298 participants · NA
EDX110 Randomized Control Trial for Treatment of DFUs
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia